(Q38325314)

2 September 2017

title

Nfkb 1 is dispensable for Myc-induced lymphomagenesis (English)

1 reference

2 September 2017

Ulrich Keller

1

1 reference

2 September 2017

Jonas A Nilsson

2

1 reference

2 September 2017

Kirsteen H Maclean

3

1 reference

2 September 2017

Jennifer B Old

4

1 reference

2 September 2017

John L Cleveland

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

2 September 2017

1 reference

2 September 2017

volume

24

1 reference

2 September 2017

issue

41

1 reference

2 September 2017

page(s)

6231-6240

1 reference

Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

The ornithine decarboxylase gene is a transcriptional target of c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Control of cell proliferation by Myc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Growth factor-deprived BALB/c 3T3 murine fibroblasts can enter the S phase after induction of c-myc gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Analysis of C-MYC function in normal cells via conditional gene-targeted mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Bim is a suppressor of Myc-induced mouse B cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Proliferation, cell cycle and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Induction of apoptosis in fibroblasts by c-myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

The Myc/Max/Mad network and the transcriptional control of cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Puma is an essential mediator of p53-dependent and -independent apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Myc pathways provoking cell suicide and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

NF-kappaB as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

NF-kappaB: tumor promoter or suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

c-Myc regulates mammalian body size by controlling cell number but not cell size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

Arf tumor suppressor promoter monitors latent oncogenic signals in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

inferred from DOI database lookup

7 January 2021

based on heuristic

c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor kappa B transactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208779

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208779

1 reference

Dimensions Publication ID

2 September 2017

1034761317

0 references

1 reference